A case-control study of melatonin receptor type 1A polymorphism and acute myocardial infarction in a Spanish population

Journal of Pineal Research

Volumn 51, Issue 4, 2011, Pages 400-404

  Samimi Fard, Sima ^a   Abreu Gonzalez, Pedro ^b   Dominguez Rodriguez, Alberto ^a   Jimenez Sosa, Alejandro ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

acute myocardial infarction; coronary artery disease; human; melatonin receptors; polymorphisms

Indexed keywords

MELATONIN 1 RECEPTOR; MELATONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RECEPTOR, MELATONIN, MT1;

EID: 80054817942     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2011.00903.x     Document Type: Article

References (42)

1. Lopez AD, Mathers CD, Ezzati M, et al., Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757. (Pubitemid 43767064)
2. Marrugat J, Elosua R, Marti H,. Epidemiology of ischaemic heart disease in Spain: estimation of the number of cases and trends from 1997 to 2005. Rev Esp Cardiol 2002; 55: 337-346. (Pubitemid 34567721)
3. Cabrera De Leon A, Rodriguez-Perez M Del C, Del Castillo- Rodriguez JC, et al., Coronary risk in the population of the Canary Islands, Spain, using the Framingham function. Med Clin (Barc) 2006; 126: 521-526. (Pubitemid 43759744)
4. Sabatine MS, Seidman JG, Seidman CE,. Cardiovascular genomics. Circulation 2006; 113: e450-e455. (Pubitemid 43739423)
5. Lusis AJ, Weinreb A, Drake TA,. Genetics of atherosclerosis. In: Textbook of Cardiovascular Medicine, Topol EJ, ed., Lippincott-Raven, Philadelphia, 1998; pp. 2389-2496.
6. Lusis AJ,. Atherosclerosis. Nature 2000; 407: 233-240.
7. Cambien F, Tiret L,. Genotype and risk of coronary heart disease. Cardiovasc Risk Fact 1997; 7: 118-128.
8. Navarro-Lopez F,. Bases geneticas de la enfermedad coronaria. Rev Esp Cardiol 2002; 55: 413-431.
9. Brugger P, Marktl W, Herold M,. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995; 345: 1408.
10. Sakotnik A, Liebmann P, Stoschitzki K, et al., Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J 1999; 20: 1314-1317. (Pubitemid 29429717)
11. Altun A, Yaprak M, Aktoz M, et al., Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X. Neurosci Lett 2002; 327: 143-145. (Pubitemid 34722427)
12. Girotti L, Lago M, Ianovsky O, et al., Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure. Endocrine 2003; 22: 245-248. (Pubitemid 38183700)
13. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia M, et al., Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res 2002; 33: 248-252. (Pubitemid 35252997)
14. Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, et al., Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 2010; 49: 14-22.
15. Paradies G, Petrosillo G, Paradies V, et al., Melatonin cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 49: 297-310.
16. Forman K, Vara E, Garcia C, et al., Beneficial effects of melatonin on cardiological alterations in a murine model of accelerated aging. J Pineal Res 2010; 49: 312-320.
17. Mukherjee D, Roy SG, Bandyopdhyay A, et al., Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms. J Pineal Res 2010; 48: 251-262.
18. Reppert SM, Godson C, Mahle CD, et al., Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 1995; 92: 8734-8738.
19. Reppert SM, Weaver DR, Ebisawa T,. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994; 13: 1177-1185. (Pubitemid 24372135)
20. Hardeland R,. Melatonin, hormone of darkness and more-ocurrente, control mechanisms, actions and bioactive metabolites. Cell Mol Life Sci 2008; 65: 2001-2018.
21. Ekmekcioglu C, Haslmayer P, Philipp C, et al., 24 h variation in the expression of the mt1 melatonin receptor subtype in coronary arteries derived from patients with coronary heart disease. Chronobiol Int 2001; 18: 973-985. (Pubitemid 34020045)
22. Ekmekcioglu C, Thalhammer T, Humpeler S, et al., The melatonin receptor subtype MT2 is present in the human cardiovascular system. J Pineal Res 2003; 35: 40-44. (Pubitemid 36819169)
23. Ekmekcioglu C, Haslmayer P, Philipp C, et al., Expression of the MT1 melatonin receptor subtype in human coronary arteries. J Recept Signal Transduct Res 2001; 21: 85-91. (Pubitemid 33009908)
24. Thygesen K, Alpert JS, White HD,. Universal definition of myocardial infarction. Joint ESC/ACCCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Eur Heart J 2007; 28: 2525-2538.
25. Bassand JP, Hamm CW, Ardissino D, et al., Guidelines for the diagnosis and treatment of non-ST-segment elevation myocardial infarction. The task force for the diagnosis and treatment of non-st-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 2007; 28: 1598-1660. (Pubitemid 47227122)
26. Sanchez JJ, Borsting C, Morling N,. Typing of Y chromosome SNPs with multiplex PCR methods. Methods Mol Biol 2005; 297: 209-222.
27. Sanchez JJ, Phillips C, Borsting C, et al., A multiplex assay with 52 single nucleotide polymorphisms for human identification. Electrophoresis 2006; 27: 1713-1724.
28. Jocker R, Maurice P, Bourn JA, et al., Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br J Pharmacol 2008; 154: 1182-1195. (Pubitemid 351992057)
29. Staiger H, Machicao F, Schafer SA, et al., Polymorphism within the novel 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS One 2008; 3: e3962.
30. Prokopenko Y, Langenberg C, Florez JC, et al., Variants in MTNR1B influence casting glucose levels. Nat Genet 2009; 41: 7-81.
31. NORA JJ, Lortscher RH, Spangler RD, et al., Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 1980; 61: 503-508. (Pubitemid 10179693)
32. Wienke A, Holm NV, Skytthe A, et al., The heritability of mortality due to heart diseases: a correlated frailty model applied to Danish twins. Twin Res 2001; 4: 266-274. (Pubitemid 34151419)
33. Zdravkovic S, Wienke A, Pedersen NL, et al., Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med 2002; 252: 247-254.
34. Ross R,. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809. (Pubitemid 23132154)
35. Ross R,. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-126.
36. Libby P,. Inflammation in atherosclerosis. Nature 2002; 420: 868-874. (Pubitemid 36019640)
37. Libby P, Ridker P, Maseri A,. Inflammation and atherosclerosis. Circulation 2002; 155: 1135-1143. (Pubitemid 34212626)
38. Esposito E, Paterniti I, Mazzon E, et al., Melatonin reduces hyperalgesia associated with inflammation. J Pineal Res 2010; 49: 321-331.
39. Reiter RJ, Tan DX,. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003; 58: 10-19. (Pubitemid 36351618)
40. Cuzzocrea S, Reiter RJ,. Pharmacological actions of melatonin in shock, inflammation and ischemic/reperfusion injury. Eur J Pharmacol 2001; 426: 1-10. (Pubitemid 32781781)
41. Dominguez-Rodriguez A, Garcia-Gonzalez M, Abreu-Gonzalez P, et al., Relation of nocturnal melatonin levels to C-reactive protein concentration in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2006; 97: 10-12. (Pubitemid 41828113)
42. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia M, et al., Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 2004; 26: 89-93. (Pubitemid 38410888)